Biomunex PharmaceuticalsBiomunex appoints new CSO The biopharmaceutical company Biomunex Pharmaceuticals announces the appointment of Dr Simon Plyte as Chief Scientific Officer (CSO) and as a member of its scientific advisory board. more ➔
VIBInternational expertise returns to Belgium VIB and Flemish Minister of Economy and Innovation, Hilde Crevits, announce the appointment of Dr Christine Durinx as VIB’s co-managing director, alongside Dr Jérôme Van Biervliet. Dr Jo Bury, co-founder … more ➔
WHOAnders Tegnell joins WHO The Swedish chief epidemiologist Anders Tegnell plans to move to the World Health Organisation (WHO) in Geneva. more ➔
SwedenBIOSwedenBIO appoints scientific relations ma... Maja Neiman is the first Science Relations Manager at SwedenBIO. The biotechnologist started her work at the end of March. more ➔
PhoreMostPhoreMost with new CEO Since the beginning of March, Dr Neil Torbett has been the new Chief Executive Officer of Cambridge-based PhoreMost Ltd. more ➔
Integra TherapeuticsIntegra Therapeutics strengthens Science A... Barcelona-based Integra Therapeutics appoints George Church to its Scientific Advisory Board. more ➔
InDex PharmaceuticalsCOO will leave InDex Pharmaceuticals InDex Pharmaceuticals needs a new COO. After ten years as Chief Operating Officer, Pernilla Sandwall will leave the Stockolm-based company at the end of April. more ➔
DiaccurateSolid financial experience for DiaccurateLaurence Riot Lamotte has started at the beginning of 2022 als new Chief Financial Officer of French Diaccurate. She succeeds José Da Gloria, who left the company. more ➔
New CEO for Galapagos Co-founder and former board member of Galapagos NV Dr Paul Stoffels will take over the position of Chief Executive Officer at the Belgian company from April. He succeeds long-time CEO Onno van de Stolpe, … more ➔
Immunovia with acting CEOImmunovia AB announces that Philipp Mathieu has been appointed as acting CEO and President with immediate effect. The search for a permanent CEO continues, as previously communicated. more ➔
